ABSTRACT
INTRODUCTION
Approximately 80% of bladder urothelial carcinomas (uC) are noninvasive (pta) tumors. These lesions recur frequently but have a good prognosis. The remainder consists of invasive (pt-4) tumors with high rate of recurrence and progression as well as aggressive clinical behavior (,2) . it is therefore quite important to decide on whether uCs have invasive features to determine their clinical behavior and the choice of treatment. in addition, if noninvasive tumors that will not show progression may be identified the number of cases not included in the clinically aggressive group will increase and these patients will avoid This study has been supported by PAubAP (project no: tPF ).
neomarkers, usA, :00, 60 minutes, high grade urothelial carcinoma), bcl-2 (00/D5, neomarkers, usA, :00, 30 minutes, follicular lymphoma), bax (2D2, neomarkers, usA, :25, 30 minutes, Hodgkin's lymphoma).
When immunohistochemical staining was evaluated, the whole section was scanned at the 0x magnification of the microscope (nikon E200) in each case and the tumor areas with the densest positive staining and the thinnest section were chosen. 40x magnification was then used to calculate the rate of positive staining cells in 000 tumor cells. nuclear staining was considered for Ki-67 and p53, and cell membrane and cytoplasmic staining for bcl-2 and bax. The threshold values used for statistical analysis were as follows: Ki-67, 3% (negative: <3%; positive: ≥3%); p53, 20% (negative: <20%; positive: ≥20%); bcl-2, % (negative: <%; positive: ≥%); bax, 20% (negative: <20%; positive:≥20%) statistical analysis of the data was performed by the sPss 0.0 statistical package software (sPss inc., Chicago, iL, usA) using the Chi-square test.
RESULTS
The age range was 40 to 84 (mean±sD: 65.5±.36) with 75 males and 9 females. All specimens were from transurethal resections (tur). re-grading according to the 2004 WHO classification revealed 2 cases of papillary urothelial neoplasm of low malignant potential, 26 lowgrade noninvasive uCs, 2 high-grade noninvasive uCs, 0 low-grade invasive uCs and 44 high-grade invasive uCs. Pathological staging revised according to the 2002 tnM revision revealed 30 noninvasive (pta) and 54 invasive (32 of pt and 22 of pt2) cases. Grouping the cases in highand low-grade histological grades revealed 38 low-grade and 46 high-grade uCs. Of the noninvasive (pta) cases, 28 were low-grade and 2 high-grade, while of the invasive (pt and pt2) cases 0 were low-grade and 44 high-grade. The number of tumors was known in 77 cases with 32 single and 45 multiple tumors. The tumor size was determined in only 42 cases; 25 were smaller than 3 cm and 7 were 3 cm or larger. 43 cases displayed papillary appearance while 4 were non-papillary. All non-papillary cases had a solid growth pattern. Accompanying foci of carcinoma in situ were present in 9 cases. One low grade and 8 high grade invasive carcinomas (5 pt and 4 pt2) harbored carcinoma in situ. One was papillary and 8 were non-papillary in appearance.
Considering pathological stage and histological grade, histological grade correlated with increasing stage (p=0.000). unnecessary treatment. The greatest expectation from the large number of studies in recent years is the identification of parameters with proven predictive value that can define the risk of progression and recurrence.
Conflicting results have been obtained regarding the effect of Ki-67, p53, bcl-2 and bax proteins on the prognosis of bladder uCs due to the lack of standards in patient selection, staining protocol and threshold values (3) (4) (5) (6) (7) (8) . There is also limited information on the expression of Ki-67, p53, bcl-2 and bax in uCs graded according to the 2004 World Health Organization (WHO) classification (,8).
Our aim in this study was to evaluate the relationship between the histopathological as well as clinical characteristics of uC (pathological stage, histological grade, multifocality, tumor size, papillary framework, and presence of carcinoma in situ) and proliferation marker Ki-67 and apoptosis markers p53, bcl-2, bax and to find out whether these parameters can be used independently or interdependently to predict the biological behavior of these tumors.
MATERIAL and METHOD
A total of 84 cases that had been investigated histopathologically at the Pamukkale university Medical Faculty Department of Pathology between April 996 and june 2003 and received a diagnosis of "uC" were included in the study. Hematoxylin-&eosin stained sections of all cases were re-evaluated and graded and staged according to the 2004 WHO classification and 2002 tnM revision, respectively (2). They were also re-evaluated whether papillary framework or carcinoma in situ were present. The clinical information of the patients was obtained from their pathology reports and patient charts.
One paraffin block best represented the tumor tissue was selected in all cases and 4-5 μm-thick sections were obtained on poly-L-lysine coated slides for immunohistochemical staining. The endogenous peroxidase activity of deparaffinized and rehydrated sections was suppressed by 3% hydrogen peroxide solution. The sections were put in a pH=7.3, 0 mM citrate buffer solution into a microwave (700 Watt) 3 times, 0 minutes each, for Ki-67 and bcl-2, and 6 times, 0 minutes each, for p53 and bax. The sections taken from the microwave were washed for 0 minutes in Pbs solution. All the following procedures were performed with the automatic method (Ventana, usA). The primary antibodies used for immunohistochemical staining (with clone, manufacturer, dilution, incubation period and positive control) were as follows: Ki-67 (Mb67, neomarkers, usA, :00, 30 minutes, tonsil), p53 (DO-7, table i summarizes the statistical comparison of Ki-67, p53, bcl-2 and bax expressions and the clinical and morphological findings. Ki-67 expression was found in 2 (25%) cases (Figure ) . A correlation was present between Ki-67 expression and pathological stage and histological grade (p=0.00; p=0.005, respectively). Ki-67 expression was significantly higher in non-papillary cases (p= 0.07).
p53 expression was found in 40 (47.6%) cases ( Figure  2 ). We found a correlation between p53 expression and pathological stage and histological grade (p=0.003; p=0.000, respectively). p53 expression was high, in a borderline significant manner, in non-papillary cases (p=0.050).
bcl-2 expression was found in 2 (2.4%) cases and bax expression in 45 (53.6%). no significant correlation was detected between bcl-2 or bax expression and clinical or pathological data (p>0.05).
DISCUSSION
The 2004 WHO classification classifies uCs that do not invade the basal membrane and stay limited to the epithelium (pta) as "noninvasive" and those that invade the lamina propria, muscle or deeper tissues (pt-4) as "invasive" (2). We used the 2004 WHO classification and graded the cases accordingly in our study.
Ki-67 is a nuclear protein coded by a gene localized to chromosome 0 and makes up part of the DnA replicase complex. This protein functions as a cellular proliferation marker and immunohistochemical Ki-67 expression is used to predict proliferative activity, and thus biological aggressiveness of the tumor (9).
Many studies on bladder uCs have found a significant relationship between the pathological stage and histological grade and Ki-67 positivity (7,0-3). Korkolopoulou et al. and Krouse et al. have shown a significant correlation between histological grade and Ki-67 positivity and observed that pta and pt bladder tumors have lower Ki-67 positivity than pt2-4 bladder tumors (0,3). Quintero et al. studied 64 ta/t uC cases and reported increased mean Ki-67 expression with increasing histological grade and tumor invasiveness (). We also found markedly higher Ki-67 expression in high grade and invasive cases than low grade and non-invasive cases in our study. Ki-67 proliferation index is expected to be higher in high grade and invasive uC than in low grade and noninvasive uC as proliferation becomes uncontrolled due to the dysregulation of cell cycle with decreased differentiation of the tumor. since papillary framework in uC is seen mostly with low grade and noninvasive tumors the high Ki-67 expression in our cases without a papillary framework, therefore, correlated with the high Ki-67 expression in invasive cases with high histological grade. Programmed cell death plays an important role in the cellular response to genotoxic stress. Loss of the apoptotic responses in tumor cells is therefore one of the mechanisms that contribute to malignant progression and cancer relapse. bcl-2 and bax are two important genes of the apoptotic pathway (6). The bcl-2 gene product protein is located in the inner mitochondrial membrane and inhibits programmed cell death, thus prolonging cell life without affecting cellular proliferation in the cells that express this oncoprotein (9) . bcl-2 prolongs cell life by inhibiting apoptosis and leads to slower neoplastic growth than that caused by the oncoproteins that stimulate cellular proliferation. Therefore one may expect bcl-2 expression to be increased in the less aggressive forms of the disease (7). investigation of the association between bcl-2 expression and the pathological stage and histological grade in uCs has shown a significant correlation between bcl-2 positivity and pathological stage and histological grade in some studies (6, 7, 8) . We found a low degree of bcl-2 positivity only in noninvasive (pta) and low-grade cases while none of the invasive (pt and pt2) and high-grade uC cases showed bcl-2 expression. These results, although not statistically significant, indicate that the bcl-2 expression found in uCs is associated with the less aggressive phenotype.
bax, bcl-2 gene family member, is a 2 kDa protein that dimerizes with bcl-2 and stimulates apoptosis (20) . Most studies on bax expression in uC have not found a correlation between bax positivity and pathological stage and histological grade (5,6,2). Ong et al. have investigated prognostic factors in 83 uC and found a correlation between increased bax positivity and increased histological grade (6). Our results also did not reveal a statistically significant relationship between bax positivity and pathological stage and histological grade in uC cases.
in conclusion, we found that Ki-67 and p53 expressions in bladder uCs increased with pathological stage and histological grade and that it was possible to obtain more accurate information about the biological behavior of uC by evaluating these parameters together with morphological findings. The results also support the observation that the 2004 WHO classification corresponds to the biological behavior of these tumors.
